Sirolimus in Kidney Transplantation Indications and Practical Guidelines: De novo Sirolimus-Based Therapy Without Calcineurin Inhibitors
Protocol Conversion From a Calcineurin Inhibitor Based Therapy to Sirolimus
Sirolimus-Based Therapy For Kidney Transplantation From Expanded Criteria Donors
Minimizing the Risk of Chronic Allograft Nephropathy
Minimizing the Risk of Posttransplant Malignancy
Management of Side Effects of Sirolimus Therapy
Inhibitors of the Mammalian Target of Rapamycin and Transplant Tolerance
Review of Symposium